Immunocytokine

This page covers all Immunocytokine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting EDB domain of fibronectin.

Targets

EDB domain of fibronectin

Phase 2 pipeline (1)

• Intratumoral injections of L19IL2 · Philogen S.p.A. · Oncology
  L19IL2 is an immunocytokine that targets the EDB domain of fibronectin, which is overexpressed in tumor vasculature, and delivers IL-2 to the tumor microenvironment to stimulate an anti-tumor immune response.

Patent intelligence

• immunocytokine patent landscape — aggregated cliff calendar, attackable patents, originator estates